Teleflex Inc.’s agreement to acquire Palette Life Sciences AB for up to $650 million to boost its urology portfolio continues the company’s strategy of acquiring assets that are accretive to its growth rate. Palette has developed a number of urology products, key among them the Barrigel, a non-animal stabilized hyaluronic acid (NASHA) spacer that reduces radiation delivered to the rectum during prostate cancer radiation therapy. With radiation treatment trends increasing, the market for Barrigel is expected to grow. Read More
During the week of July 24, 2023, the FDA published several notifications of potentially elevated risks associated with medical devices, including a recall of a delivery sheath for the Amplatzer device by Abbott Laboratories. The agency also announced that Abiomed Inc. will provide a correction for the instructions for use (IFUs) for the Impella because of an issue seen when implanting the left ventricular assist device in patients with transcatheter aortic valve replacement (TAVR) devices. Read More
Arsenal Medical Inc. said its Neocast embolic material for neurovascular conditions was successfully used to treat its first patient. The patient was embolized as part of a first-in-human study to assess the safety and feasibility of Neocast for the embolization of brain tumors to more easily enable surgical removal. Read More
The identification of new targets in diseases of the central nervous system (CNS) such as Alzheimer’s and Parkinson’s – conditions which continue to have significant unmet needs – has taken a small step forward as one company, Violet Therapeutics Inc., plans to put $10.6 million in seed funding toward building out a pipeline based on technologies that elucidate the way cells interact amongst one another. Read More
Researchers from the University of Shanghai for Science and Technology have developed an electrotechnical patch, printed on a wearable substrate, capable of detecting dopamine and glucose levels in real-time. They published their work in Analytica. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ambica, Delfi, Emvenio, Koru, Medipines, Natera, Trialhub, Unify Medical. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ultrasight. Read More
